Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -98.21% is 100% above its 5-year average of -30250.23%, near the high end of its 5-year range (-180928.57%–12.94%).
88.26% above its 12-month average of -836.41%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3835.26%.
OPERATING MARGIN
-98.21%
OPERATING MARGIN AVG TTM
-836.41%
OPERATING MARGIN AVG 3Y
-2182.73%
OPERATING MARGIN AVG 5Y
-30250.23%
OPERATING MARGIN AVG 10Y
-1636.12%
OPERATING MARGIN AVG 15Y
-3647.31%
OPERATING MARGIN AVG 20Y
-2901.28%
CURRENT VS TTM AVG
+88.26%
CURRENT VS 3Y AVG
+95.50%
CURRENT VS 5Y AVG
+99.68%
CURRENT VS 10Y AVG
+94.00%
CURRENT VS 15Y AVG
+97.31%
CURRENT VS 20Y AVG
+96.61%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 649 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Lexicon Pharmaceuticals, Inc.
Market Cap
$781.78M
Operating Margin
-98.21%
TTM Avg
-836.41%
3Y Avg
-2182.73%
5Y Avg
-30250.23%
Market Cap
$785.93M
Operating Margin
-0.31%
TTM Avg
6.92%
3Y Avg
0.39%
5Y Avg
2.91%
Market Cap
$789.07M
Operating Margin
-29.28%
TTM Avg
-127.46%
3Y Avg
-26333.62%
5Y Avg
-23986.43%
Market Cap
$794.93M
Operating Margin
9.86%
TTM Avg
12.61%
3Y Avg
-6.26%
5Y Avg
-239.99%
Market Cap
$765.72M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$764.06M
Operating Margin
9.00%
TTM Avg
7.11%
3Y Avg
-27.53%
5Y Avg
-16.39%
Market Cap
$755.50M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6934.80%
5Y Avg
-9894.67%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals, Inc. (LXRX) | $781.78M | -98.21% | -836.41% | -2182.73% | -30250.23% |
| AdaptHealth Corp. (AHCO)vs › | $785.93M | -0.31% | 6.92% | 0.39% | 2.91% |
| Geron Corporation (GERN)vs › | $789.07M | -29.28% | -127.46% | -26333.62% | -23986.43% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $794.93M | 9.86% | 12.61% | -6.26% | -239.99% |
| Design Therapeutics, Inc. (DSGN)vs › | $765.72M | 0.00% | 0.00% | 0.00% | 0.00% |
| Apnimed, Inc. (APMD)vs › | $799.05M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $764.06M | 9.00% | 7.11% | -27.53% | -16.39% |
| InMode Ltd. (INMD)vs › | $802.95M | 18.47% | 25.77% | 33.72% | 36.17% |
| Candel Therapeutics, Inc. (CADL)vs › | $755.50M | 0.00% | 0.00% | -6934.80% | -9894.67% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $755.18M | -4974.74% | -2487.37% | -2487.37% | -2487.37% |
Gross Margin
98.8%
Operating Margin
-98.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -3835.26% |
| 2026-03-31 | -4.72% |
| 2025-12-31 | -269.07% |
| 2025-09-30 | -85.93% |
| 2025-06-30 | 12.94% |
| 2025-03-31 | -2034.79% |
| 2024-12-31 | -123.28% |
| 2024-09-30 | -3639.60% |
| 2024-06-30 | -3360.90% |
| 2024-03-31 | -4011.77% |
| 2023-12-31 | -6657.69% |
| 2023-09-30 | -30636.42% |
| 2023-06-30 | -13955.84% |
| 2023-03-31 | -129758.33% |
| 2022-12-31 | -108135.71% |
| 2022-09-30 | -59217.95% |
| 2022-06-30 | -68591.43% |
| 2022-03-31 | -63189.19% |
| 2021-12-31 | -180928.57% |
| 2021-09-30 | -99834.78% |
| 2021-06-30 | -7674.79% |
| 2021-03-31 | -77181.48% |
| 2020-12-31 | -3747.74% |
| 2020-09-30 | 1306.53% |
| 2020-06-30 | -704.78% |
| 2020-03-31 | -780.57% |
| 2019-12-31 | -541.05% |
| 2019-09-30 | 76.30% |
| 2019-06-30 | -191.54% |
| 2019-03-31 | -189.55% |
| 2018-12-31 | -72.44% |
| 2018-09-30 | -336.10% |
| 2018-06-30 | -221.25% |
| 2018-03-31 | -150.62% |
| 2017-12-31 | -93.16% |
| 2017-09-30 | -109.56% |
| 2017-06-30 | -281.20% |
| 2017-03-31 | -232.25% |
| 2016-12-31 | -136.00% |
| 2016-09-30 | -126.03% |
| 2016-06-30 | -184.28% |
| 2016-03-31 | -271.10% |
| 2015-12-31 | 69.42% |
| 2015-09-30 | -5950.00% |
| 2015-06-30 | -7097.87% |
| 2015-03-31 | -1480.30% |
| 2014-12-31 | -16.05% |
| 2014-09-30 | -9626.73% |
| 2014-06-30 | -3862.57% |
| 2014-03-31 | -11000.72% |
| 2013-12-31 | -1203.97% |
| 2013-09-30 | -13115.97% |
| 2013-06-30 | -13375.70% |
| 2013-03-31 | -7098.61% |
| 2012-12-31 | -11234.86% |
| 2012-09-30 | -7811.83% |
| 2012-06-30 | -12804.02% |
| 2012-03-31 | -9794.33% |
| 2011-12-31 | -9720.70% |
| 2011-09-30 | -7236.90% |
| 2011-06-30 | -4671.35% |
| 2011-03-31 | -4888.59% |
| 2010-12-31 | -1789.70% |
| 2010-09-30 | -3105.38% |
| 2010-06-30 | -1952.47% |
| 2010-03-31 | -1521.39% |
| 2009-12-31 | -1547.24% |
| 2009-09-30 | -1020.98% |
| 2009-06-30 | -762.19% |
| 2009-03-31 | -565.50% |
| 2008-12-31 | -328.96% |
| 2008-09-30 | -330.43% |
| 2008-06-30 | -275.83% |
| 2008-03-31 | -274.80% |
| 2007-12-31 | -133.74% |
| 2007-09-30 | -191.23% |
| 2007-06-30 | -141.92% |
| 2007-03-31 | -141.50% |
| 2006-12-31 | -90.70% |
| 2006-09-30 | -64.78% |
| 2006-06-30 | -104.76% |
| 2006-03-31 | -52.59% |
| 2005-12-31 | 16.88% |
| 2005-09-30 | -100.66% |
| 2005-06-30 | -104.47% |
| 2005-03-31 | -95.27% |
| 2004-12-31 | -5.61% |
| 2004-09-30 | -106.41% |
| 2004-06-30 | -152.57% |
| 2004-03-31 | -131.76% |
| 2003-12-31 | -90.08% |
| 2003-09-30 | -122.76% |
| 2003-06-30 | -200.11% |
| 2003-03-31 | -216.28% |
| 2002-12-31 | -144.12% |
| 2002-09-30 | -218.28% |
